Table 1.
Comparison of the demographic features and laboratory data of all the patients according to thrombus burden*
| Variables | High Thrombus Burden (n=154) |
Low Thrombus Burden (n=103) |
P |
|---|---|---|---|
| Age, (y) | 63.42±11.53 | 61.50±10.23 | 0.186 |
| Sex, (male) | 101 (65.6) | 73 (70.9) | 0.374 |
| History | |||
| Diabetes mellitus | 36 (23.4) | 20 (19.4) | 0.451 |
| Hypertension | 64 (41.6) | 35 (34.0) | 0.221 |
| Cigarette smoking | 65 (42.2) | 49 (47.6) | 0.396 |
| Vascular disease | 3 (1.9) | 2 (1.9) | 1.000 |
| Previous history of CAD | 26 (16.9) | 16 (15.5) | 0.774 |
| Family history of CAD | 48 (31.2) | 27 (26.2) | 0.392 |
| Systolic blood pressure, (mmHg) | 120 (117.5-130) | 130 (120-130) | 0.139 |
| Heart rate, (beat/min) | 85.5 (78-92.5) | 85 (75-90) | 0.103 |
| Laboratory Results | |||
| CRP, (mg/dL) | 3.50±2-60 | 2.30±2-3.10 | 0.001 |
| Albumin, (g/dL) | 4 (3.1-4.2) | 4.1 (3.8-4.3) | 0.001 |
| White blood cell count, (x103/mL) | 10.3 (8.9-12.8) | 9.6 (7.7-10.7) | <0.001 |
| Hemoglobin, (g/dL) | 14.7 (13.6-15.6) | 15 (14-15.8) | 0.230 |
| Neutrophil, (x103/mL) | 7.9 (6.3-9.8) | 6.2 (4.9-7.6) | <0.001 |
| Lymphocyte, (x103/mL) | 1.8 (1.3-2.3) | 2.1 (1.5-2.6) | 0.019 |
| Platelet count, (x103/mL) | 230 (192-257) | 214 (182-265) | 0.372 |
| Cardiac troponin I, (mg/L) | 2.3 (0.2-12.3) | 0.3 (0.1-2.2) | <0.001 |
| Total cholesterol, (mg/dL) | 176 (143-202) | 161 (145-198) | 0.302 |
| LDL cholesterol, (mg/dL) | 111.53±35.24 | 104.31±33.93 | 0.103 |
| HDL cholesterol, (mg/dL) | 39 (32-42) | 38 (33-44) | 0.222 |
| Triglyceride, (mg/dL) | 94 (75-136) | 110 (78-201) | 0.027 |
| Creatinine, (mg/dL) | 1 (0.8-1) | 0.9 (0.8-1) | 0.079 |
| Vitamin D, (ng/mL) | 8 (5.6-10.5) | 17.9 (14.6-24) | <0.001 |
| Parathyroid hormone, (pg/mL) | 45 (28-60) | 36 (23-47) | 0.001 |
| Calcium, (mg/dL) | 8.9 (8.8-9) | 9 (8.9-9) | 0.202 |
| Left ventricular EF, (%) | 45 (40-45) | 50 (45-55) | <0.001 |
| Previous Medications | |||
| Antiplatelet | 7 (4.6) | 8 (7.8) | 0.291 |
| Aspirin | 28 (18.2) | 22 (21.4) | 0.528 |
| Statin | 21 (13.6) | 19 (18.5) | 0.297 |
| ACE inhibitors/ARB | 32 (20.8) | 23 (22.3) | 0.766 |
| Beta-blocker | 25 (16.2) | 20 (19.4) | 0.511 |
CAD, Coronary artery disease; CRP, C-reactive protein; LDL, Low-density lipoprotein; HDL, High-density lipoprotein; EF, Ejection fraction; ACE, Angiotensin-converting enzyme; ARB, Angiotensin-receptor blocker
*
Data are presented as mean±SD, median (IQ25% –75% ), or n (%)